ALYFTREK Trademark

Trademark Overview


On Tuesday, December 19, 2023, a trademark application was filed for ALYFTREK with the United States Patent and Trademark Office. The USPTO has given the ALYFTREK trademark a serial number of 98321063. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Thursday, July 10, 2025. This trademark is owned by Vertex Pharmaceuticals Incorporated. The ALYFTREK trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cystic fibrosis
alyftrek

General Information


Serial Number98321063
Word MarkALYFTREK
Filing DateTuesday, December 19, 2023
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateThursday, July 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 7, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cystic fibrosis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 19, 2023
Primary Code005
First Use Anywhere DateWednesday, January 8, 2025
First Use In Commerce DateWednesday, January 8, 2025

Trademark Owner History


Party NameVertex Pharmaceuticals Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Party NameVertex Pharmaceuticals Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events


Event DateEvent Description
Tuesday, December 19, 2023NEW APPLICATION ENTERED
Wednesday, March 27, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 29, 2024ASSIGNED TO EXAMINER
Friday, March 29, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 7, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 2, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, December 9, 2024SOU TEAS EXTENSION RECEIVED
Monday, December 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 9, 2024SOU EXTENSION 1 GRANTED
Monday, December 9, 2024SOU EXTENSION 1 FILED
Monday, February 10, 2025USE AMENDMENT FILED
Monday, February 10, 2025TEAS STATEMENT OF USE RECEIVED
Thursday, April 17, 2025STATEMENT OF USE PROCESSING COMPLETE
Monday, April 28, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 10, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, July 16, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED